Published in Nat Med on May 30, 2010
Mast cells and inflammation. Biochim Biophys Acta (2010) 1.91
Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med (2012) 1.63
Protective and pathological roles of mast cells and basophils. Nat Rev Immunol (2013) 1.54
Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus. Front Immunol (2017) 1.40
The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol (2012) 1.36
Basophils and allergic inflammation. J Allergy Clin Immunol (2013) 1.29
Vaccination strategies to promote mucosal antibody responses. Immunity (2010) 1.24
Circulating TFH subset distribution is strongly affected in lupus patients with an active disease. PLoS One (2013) 1.23
The skin is an important bulwark of acquired immunity against intestinal helminths. J Exp Med (2013) 1.11
Innate immune cells in liver inflammation. Mediators Inflamm (2012) 1.11
Targeting BAFF in autoimmunity. Curr Opin Immunol (2010) 1.08
Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy (2012) 1.08
Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS One (2014) 1.07
T cells that promote B-Cell maturation in systemic autoimmunity. Immunol Rev (2012) 1.06
Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. J Immunol (2012) 1.03
B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc Natl Acad Sci U S A (2011) 1.01
New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation. Ann N Y Acad Sci (2011) 1.00
Thymic stromal lymphopoietin-dependent basophils promote Th2 cytokine responses following intestinal helminth infection. J Immunol (2012) 1.00
Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol (2015) 0.99
Chronic helminth infection reduces basophil responsiveness in an IL-10-dependent manner. J Immunol (2012) 0.94
Functional heterogeneity in the basophil cell lineage. Adv Immunol (2012) 0.92
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest (2015) 0.92
Circulating human basophils lack the features of professional antigen presenting cells. Sci Rep (2013) 0.92
B-cell activating factor targeted therapy and lupus. Arthritis Res Ther (2012) 0.92
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus. J Interferon Cytokine Res (2011) 0.91
Basophils control T-cell responses and limit disease activity in experimental murine colitis. Mucosal Immunol (2013) 0.91
The role of cytokine in the lupus nephritis. J Biomed Biotechnol (2011) 0.90
Basophils and autoreactive IgE in the pathogenesis of systemic lupus erythematosus. Curr Allergy Asthma Rep (2011) 0.89
Immunoglobulin E plays an immunoregulatory role in lupus. J Exp Med (2014) 0.88
Basophils, IgE, and autoantibody-mediated kidney disease. J Immunol (2011) 0.88
The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy. Gut Microbes (2016) 0.86
Emerging role of human basophil biology in health and disease. Curr Allergy Asthma Rep (2014) 0.85
Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun (2016) 0.84
The expression of CD123 can decrease with basophil activation: implications for the gating strategy of the basophil activation test. Clin Transl Allergy (2016) 0.84
Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice. Toxicology (2011) 0.84
Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis Model Mech (2014) 0.84
Activation of B cells by non-canonical helper signals. EMBO Rep (2012) 0.84
Interrogation of sphingosine-1-phosphate receptor 2 function in vivo reveals a prominent role in the recovery from IgE and IgG-mediated anaphylaxis with minimal effect on its onset. Immunol Lett (2013) 0.83
Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy. J Immunol (2011) 0.83
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Int J Mol Sci (2012) 0.82
Basophil-derived IL-4 plays versatile roles in immunity. Semin Immunopathol (2016) 0.82
Understanding the roles of basophils: breaking dawn. Immunology (2012) 0.81
New insights into basophil heterogeneity. Semin Immunopathol (2016) 0.81
New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 0.81
IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. Eur J Immunol (2012) 0.80
Basophils inhibit proliferation of CD4⁺ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host disease. Immunology (2015) 0.80
Transcriptional regulation of mast cell and basophil lineage commitment. Semin Immunopathol (2016) 0.80
Role of basophils in the pathogenesis of minimal change nephrotic syndrome: A literature review. Exp Ther Med (2014) 0.80
MHC class II expression in human basophils: induction and lack of functional significance. PLoS One (2013) 0.79
IL-3 contributes to development of lupus nephritis in MRL/lpr mice. Kidney Int (2015) 0.79
Basophils from humans with systemic lupus erythematosus do not express MHC-II. Nat Med (2012) 0.78
Basophils and skin disorders. J Invest Dermatol (2014) 0.78
Activated basophils give lupus a booster shot. Nat Med (2010) 0.78
Downregulation of TIM-3 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Braz J Med Biol Res (2014) 0.78
Mannose-binding lectin blunts macrophage polarization and ameliorates lupus nephritis. PLoS One (2013) 0.78
Role of basophils in rheumatoid arthritis (Review). Exp Ther Med (2015) 0.78
Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency. Immunol Cell Biol (2015) 0.78
A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight (2016) 0.77
The deleterious role of basophils in systemic lupus erythematosus. Curr Opin Immunol (2013) 0.77
Basophil count, a marker for disease activity in systemic lupus erythematosus. Clin Rheumatol (2014) 0.77
Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides-As Antigens for Th Cells. Front Immunol (2015) 0.76
Lupus nephritis: Activated basophils exacerbate lupus nephritis by amplifying production of autoreactive IgE. Nat Rev Rheumatol (2010) 0.76
Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond. Int Arch Allergy Immunol (2014) 0.75
Non-pathogenic tissue-resident CD8(+) T cells uniquely accumulate in the brains of lupus-prone mice. Sci Rep (2017) 0.75
Association of c-Jun gene polymorphism with susceptibility to systemic lupus erythematosus in a Chinese population. DNA Cell Biol (2012) 0.75
Lupus pathogenesis: role of IgE autoantibodies. Cell Res (2016) 0.75
Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology (Oxford) (2017) 0.75
Association between allergic diseases and risks of HSP and HSP nephritis: a population-based study. Pediatr Res (2015) 0.75
The influence of commensal bacteria-derived signals on basophil-associated allergic inflammation. Gut Microbes (2012) 0.75
CTLA4Fcε, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation. Immunology (2016) 0.75
The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions. Biomed Res Int (2016) 0.75
Autoimmunity: New players in lupus nephritis. Nat Rev Immunol (2010) 0.75
Measuring eosinophiluria, urinary eosinophil cationic protein and urinary interleukin-5 in patients with Lupus Nephritis. Allergy Asthma Clin Immunol (2014) 0.75
Basophils contribute to pristane-induced Lupus-like nephritis model. Sci Rep (2017) 0.75
Treatment with anti-FcεRIα antibody exacerbates EAE and T-cell immunity against myelin. Neurol Neuroimmunol Neuroinflamm (2017) 0.75
[Basophilic granulocytes and autoimmune diseases : Can basophilic granulocytes modulate B-cell functions in systemic lupus erythematosus?]. Z Rheumatol (2016) 0.75
Atopy in children with the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis is associated with a worse outcome. Eur J Pediatr (2015) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Systemic lupus erythematosus. N Engl J Med (2008) 10.22
A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol (2008) 6.78
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69
Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (1993) 6.54
MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol (2009) 4.28
Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol (2009) 3.82
Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol (2009) 3.79
Autoreactivity in human IgG+ memory B cells. Immunity (2007) 3.71
Basophils enhance immunological memory responses. Nat Immunol (2008) 3.35
Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol (2007) 3.22
Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell (1995) 3.17
Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun (2009) 2.78
T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci U S A (2002) 2.63
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest (1998) 2.60
A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med (2006) 2.60
Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity (1995) 2.50
Active anaphylaxis in IgE-deficient mice. Nature (1994) 2.32
Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med (2009) 2.21
Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity (2005) 2.19
Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum (1999) 2.18
Regulation of mast cell survival by IgE. Immunity (2001) 2.11
Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity (2001) 2.11
Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest (1997) 2.04
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol (2009) 1.97
Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol (2009) 1.95
Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med (2004) 1.91
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum (2004) 1.69
Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum (2001) 1.61
Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr Biol (2001) 1.58
Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest (2003) 1.55
Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol (2004) 1.53
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol (2002) 1.47
Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep (2009) 1.19
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol (2005) 1.18
Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity (2009) 1.17
Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med (2009) 1.17
Genetic associations of LYN with systemic lupus erythematosus. Genes Immun (2009) 1.15
B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med (2001) 1.13
Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity. J Immunol (2005) 1.11
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol (2009) 1.07
Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. J Clin Invest (1995) 1.06
Identification and partial characterization of a unique marker for human basophils. J Immunol (1995) 1.04
Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) (2008) 1.03
Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci (2009) 1.02
Human pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma. J Clin Pharmacol (2009) 0.98
Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity (1994) 0.94
Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res (2004) 0.92
Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA/1 mice and spontaneous arthritis in MRL/lpr mice. Autoimmunity (1991) 0.91
New concepts: the basophil. J Allergy Clin Immunol (1997) 0.90
Development and characterization of a monoclonal antibody specific for human basophils and the identification of a unique secretory product of basophil activation. Lab Invest (1999) 0.89
Development of lupus in BXSB mice is independent of IL-4. J Immunol (2000) 0.88
New insights into the pathogenesis of systemic lupus erythematosus. Curr Rheumatol Rep (2005) 0.86
A shift in the Th(1)/Th(2) ratio accompanies the clinical remission of systemic lupus erythematosus in patients with end-stage renal disease. Nephrol Dial Transplant (2002) 0.83
Isolation and analysis of nephritic-producing immune complexes in Plasmodium berghei-infected mice. J Natl Med Assoc (1995) 0.80
IgE allotypes in sera of mice with autoimmune diseases and in mice with graft-versus-host disease after transfusion or bone marrow transplantation. Int Arch Allergy Immunol (1996) 0.79
Maternal and child undernutrition: global and regional exposures and health consequences. Lancet (2008) 26.44
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med (2014) 5.98
Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2002) 3.88
Improvement of child survival in Mexico: the diagonal approach. Lancet (2006) 3.87
Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62
Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol (2002) 3.60
The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One (2012) 3.14
The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity (2007) 2.83
Platelet formation is the consequence of caspase activation within megakaryocytes. Blood (2002) 2.62
Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med (2004) 2.44
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature (2013) 2.36
The tyrosine kinase network regulating mast cell activation. Immunol Rev (2009) 2.29
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum (2003) 2.11
Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion (2003) 2.05
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol (2009) 2.03
The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol (2004) 2.01
CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity (2008) 1.95
Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med (2004) 1.91
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum (2006) 1.87
Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int (2008) 1.86
DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol (2002) 1.81
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet (2013) 1.79
Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells. J Leukoc Biol (2010) 1.73
Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie (2002) 1.70
Acute renal infarction: a case series. Clin J Am Soc Nephrol (2012) 1.68
AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene (2004) 1.68
Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J Pediatr Gastroenterol Nutr (2007) 1.66
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int (2011) 1.64
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest (2003) 1.63
MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol (2010) 1.59
miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol (2013) 1.57
Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull (2010) 1.55
IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J Biol Chem (2005) 1.55
Molecular editing of cellular responses by the high-affinity receptor for IgE. Science (2014) 1.53
Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene (2003) 1.52
E-prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA-mediated suppression of IgE-dependent signaling. J Leukoc Biol (2012) 1.47
Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med (2003) 1.42
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (2012) 1.38
Evidence of a role for Munc18-2 and microtubules in mast cell granule exocytosis. J Cell Sci (2003) 1.38
Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol (2009) 1.38
Cutting Edge: Lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J Immunol (2006) 1.35
Multiple micronutrient supplementation during pregnancy does not lead to greater infant birth size than does iron-only supplementation: a randomized controlled trial in a semirural community in Mexico. Am J Clin Nutr (2003) 1.33
Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest (2010) 1.31
MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum (2011) 1.31
Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome. Autoimmunity (2009) 1.31
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity (2012) 1.30
Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J Immunol (2005) 1.28
Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J (2012) 1.27
Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. J Immunol (2007) 1.26
VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood (2008) 1.26
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis Rheum (2004) 1.25
Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J Immunol (2005) 1.24
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells. Blood (2004) 1.23
Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis (2007) 1.22
Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells. Cell Signal (2007) 1.21
The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J Exp Med (2003) 1.21
Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol (2013) 1.19
Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity (2009) 1.17
Cytokines in Sjogren's syndrome: potential therapeutic targets. Ann Rheum Dis (2010) 1.15
Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity (2011) 1.15
Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol (2009) 1.15
Renal involvement in Castleman disease. Nephrol Dial Transplant (2010) 1.13
Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome. Clin J Am Soc Nephrol (2009) 1.10
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus. Ann Rheum Dis (2012) 1.10
Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr (2003) 1.10
Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum (2006) 1.09
Early activation of sphingosine kinase in mast cells and recruitment to FcepsilonRI are mediated by its interaction with Lyn kinase. Mol Cell Biol (2004) 1.09
Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland. J Gene Med (2010) 1.09
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med (2012) 1.08
The FcepsilonRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. J Biol Chem (2004) 1.08
Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum (2006) 1.06
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J Exp Med (2006) 1.05
Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. J Immunol (2012) 1.03
Munc18-2/syntaxin3 complexes are spatially separated from syntaxin3-containing SNARE complexes. FEBS Lett (2003) 1.03
Adapters in the organization of mast cell signaling. Immunol Rev (2009) 1.03
Assays for regulated exocytosis of mast cell granules. Curr Protoc Cell Biol (2006) 1.02
Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity. Proc Natl Acad Sci U S A (2005) 1.01
TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J Immunol (2005) 1.00
Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta (2005) 0.99
An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. Adv Exp Med Biol (2011) 0.99
Oxidative stress stimulates IL-4 and IL-6 production in mast cells by an APE/Ref-1-dependent pathway. Eur J Immunol (2003) 0.99
Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol (2007) 0.98
Vav1 is a component of transcriptionally active complexes. J Exp Med (2002) 0.98
Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. J Immunol (2010) 0.97
Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. Handb Exp Pharmacol (2009) 0.96
[Factors associated with physical activity among Mexican women of childbearing age]. Rev Panam Salud Publica (2003) 0.96
IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species. J Immunol (2008) 0.95
Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice. J Immunol (2009) 0.95
Dietary intakes of polyunsaturated fatty acids among pregnant Mexican women. Matern Child Nutr (2011) 0.95
The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations. Cell Microbiol (2005) 0.95
Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors. Clin Exp Rheumatol (2012) 0.95
Mast cell and T cell communication; amplification and control of adaptive immunity. Immunol Lett (2009) 0.95
IL-10 inhibits Fc epsilon RI expression in mouse mast cells. J Immunol (2004) 0.94
MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun Rev (2010) 0.94
Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol (2007) 0.94
The Oportunidades program increases the linear growth of children enrolled at young ages in urban Mexico. J Nutr (2008) 0.93
Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas. Pituitary (2009) 0.92
Parallel deficits in linear growth and mental development in low-income Mexican infants in the second year of life. Public Health Nutr (2006) 0.91